MedTrace Logo

Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer

NCT05285319 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-08-10

No results posted yet for this study

Summary

This phase II randomized controlled study aims to compare the treatment results of intermediate and high risk prostate cancer patients treated with hormonal therapy and radical radiotherapy with or without pelvic lymph nodes in NCI- Cairo University.

Conditions

Interventions

RADIATION

Prostate Only Radiation

Prostate Only Radiation for Intermediate and High Risk Prostate cancer

RADIATION

Prostate and Pelvic Lymph Node Radiation

Prostate and Pelvic Lymph Node Radiation for Intermediate and High Risk Prostate cancer

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-09
Primary Completion
2022-04-01
Completion
2023-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05285319 on ClinicalTrials.gov